MENU
+Compare
PJP
ETF ticker: NYSE ARCA
AS OF
Apr 2 closing price
Price
$84.45
Change
+$0.57 (+0.68%)
Net Assets
253.5M

PJP stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index... Show more

Category: #Health
PJP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for PJP with price predictions
Apr 01, 2025

PJP in downward trend: 10-day moving average crossed below 50-day moving average on March 19, 2025

The 10-day moving average for PJP crossed bearishly below the 50-day moving average on March 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PJP as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PJP turned negative on April 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

PJP moved below its 50-day moving average on April 01, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PJP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PJP broke above its upper Bollinger Band on March 31, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PJP entered a downward trend on March 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where PJP's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PJP advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Pharmaceuticals ETF ETF is 114.4B. The market cap for tickers in the group ranges from 1.01B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is GERN at 1.01B.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Pharmaceuticals ETF ETF was 1%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was -2%. CORT experienced the highest price growth at 47%, while BIIB experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Invesco Pharmaceuticals ETF ETF was 33%. For the same stocks of the ETF, the average monthly volume growth was 8% and the average quarterly volume growth was 141%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 60
Price Growth Rating: 51
SMR Rating: 59
Profit Risk Rating: 50
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
PJP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Powershares Exchange Traded Fund Trust227 E Prairie AveWheaton
Phone
N/A
Web
www.invescopowershares.com